Glenn Wilkins - Wednesday, January 17, 2018 Antibe Therapeutics Inc. 11:35 AM EST - Antibe Therapeutics Inc. : Has engaged Brand Institute, Inc. to advise on the nonproprietary name for its lead drug candidate, ATB-346. Antibe Therapeutics Inc. shares V.ATE are trading up $0.01 at $0.20.